STL Index for: Sophie Guénin
Real World Canadian Case Series: Use of Tildrakizumab for Moderate-to-Severe Psoriasis
Real-world evidence from 7 Canadian cases shows tildrakizumab effectively treats moderate-to-severe psoriasis with excellent safety profile and patient satisfaction.
